Mereo BioPharma (MREO) Receivables - Other (2017 - 2023)
Mereo BioPharma (MREO) posted quarterly Receivables - Other of $2.0 million for Q4 2023, up 118.18% year-over-year from $893771.4 in Q4 2022, and up 118.18% quarter-over-quarter from $893771.4 in Q4 2022.
Mereo BioPharma (MREO) Receivables - Other (2017 - 2023) Analysis & Trends
Mereo BioPharma (MREO) has reported Receivables - Other for 7 consecutive years, with $2.0 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Receivables - Other rose 118.18% year-over-year to $2.0 million; the TTM figure through Dec 2023 stood at $2.0 million (up 118.18% YoY), while the FY2023 annual figure was $2.0 million, changed N/A from the prior year.
- Receivables - Other advanced to $2.0 million in Q4 2023 per MREO's latest filing, from $893771.4 in the prior quarter.
- Across five years, Receivables - Other topped out at $2.5 million in Q2 2019 and bottomed at $735434.6 in Q4 2019.
- Historically, Receivables - Other has averaged $1.5 million across 5 years, with a median of $1.4 million in 2021.
- Annual changes were most pronounced in 2021 — Receivables - Other soared 124.24% — and 2022, when it tumbled 53.27%.
- Mereo BioPharma's Receivables - Other stood at $735434.6 in 2019, then rose by 15.99% to $853011.3 in 2020, then jumped by 124.24% to $1.9 million in 2021, then sank by 53.27% to $893771.4 in 2022, then jumped by 118.18% to $2.0 million in 2023.
- Business Quant data shows MREO's Receivables - Other at $2.0 million in Q4 2023, $893771.4 in Q4 2022, and $1.3 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.95 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | 893,771.38 |
| Dec 31, 2022 | 893,771.38 |
| Jun 30, 2022 | 1.27 Mn |
| Jun 30, 2022 | 1.27 Mn |
| Dec 31, 2021 | 1.91 Mn |
| Dec 31, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.44 Mn |
| Jun 30, 2021 | 1.44 Mn |
| Dec 31, 2020 | 853,011.35 |
| Dec 31, 2020 | 853,011.35 |
| Jun 30, 2020 | 2.28 Mn |
| Jun 30, 2020 | 2.28 Mn |
| Dec 31, 2019 | 735,434.65 |
| Dec 31, 2019 | 735,434.65 |
| Jun 30, 2019 | 2.51 Mn |
| Jun 30, 2019 | 2.51 Mn |
| Dec 31, 2018 | 783,641.24 |
| Dec 31, 2018 | 783,641.24 |